Lu Hua, Shi Ji-Xin, Chen Hui-Lin, Hang Chun-Hua, Wang Han-Dong, Yin Hong-Xia
Department of Neurosurgery, Jinling Hospital, Clinical School of Nanjing University, 305 East Zhongshan Road, Nanjing 210002, China.
Brain Res. 2009 Mar 25;1262:73-80. doi: 10.1016/j.brainres.2009.01.017. Epub 2009 Jan 21.
Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that plays an important role in the recruitment of macrophages. Although previous studies have demonstrated that MCP-1 has been shown to be involved in the damaging inflammatory processes associated with stroke, infection, neoplasia, and others in the central nervous system, the role of MCP-1 in the cerebral artery after experimental subarachnoid hemorrhage (SAH) in rats has been largely unexplored. This study was undertaken to investigate the expression of the MCP-1 in SAH model and to clarify the potential role of MCP-1 in cerebral vasospasm. A total of 80 rats were randomly divided into four groups: control group; day 3, day 5, and day 7 groups. Day 3, day 5, and day 7 groups were all SAH groups. The animals in day 3, day 5 and day 7 groups were subjected to injection of autologous blood into cisterna magna twice on day 0 and day 2 and were killed on days 3, 5, and 7, respectively. Cross-sectional area of basilar artery was measured and the MCP-1 expression was assessed by real-time PCR, Western blot and immunohistochemistry. The cross-sectional area of basilar artery was found to be 85,373+/-8794 mum(2) in control group, 59,210+/-7281 mum(2) in day 3, 50,536+/-6519 mum(2) in day 5, and 66,360+/-7452 mum(2) in day 7, respectively. The basilar arteries exhibited vasospasm after SAH and became more severe on day 5. The elevated mRNA and protein of MCP-1 were detected after SAH and peaked on day 5. MCP-1 is increasingly expressed in a parallel time course to the development of cerebral vasospasm in a rat experimental model of SAH and these findings might have important implications during the administration of specific MCP-1 antagonists in order to prevent or reduce cerebral vasospasm caused by SAH.
单核细胞趋化蛋白-1(MCP-1)是一种强效趋化因子,在巨噬细胞募集过程中发挥重要作用。尽管先前的研究表明,MCP-1已被证明参与了与中风、感染、肿瘤形成及中枢神经系统其他疾病相关的破坏性炎症过程,但MCP-1在大鼠实验性蛛网膜下腔出血(SAH)后脑血管中的作用在很大程度上尚未得到探索。本研究旨在探讨MCP-1在SAH模型中的表达情况,并阐明MCP-1在脑血管痉挛中的潜在作用。总共80只大鼠被随机分为四组:对照组;第3天、第5天和第7天组。第3天、第5天和第7天组均为SAH组。第3天、第5天和第7天组的动物在第0天和第2天两次经枕大池注射自体血,并分别在第3天、第5天和第7天处死。测量基底动脉的横截面积,并通过实时聚合酶链反应、蛋白质印迹法和免疫组织化学评估MCP-1的表达。发现对照组基底动脉的横截面积为85,373±8794μm²,第3天为59,210±7281μm²,第5天为50,536±6519μm²,第7天为66,360±7452μm²。SAH后基底动脉出现血管痉挛,在第5天变得更加严重。SAH后检测到MCP-1的mRNA和蛋白质水平升高,并在第5天达到峰值。在大鼠SAH实验模型中,MCP-1的表达随脑血管痉挛的发展呈平行时间进程增加,这些发现可能对使用特定MCP-1拮抗剂预防或减轻SAH所致脑血管痉挛具有重要意义。